⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25041179 | 0.78 | — | — | |
| SCHEMBL20987453 | 0.78 | — | — | |
| SCHEMBL25164614 | 0.77 | — | — | |
| SCHEMBL21959259 | 0.76 | — | — | |
| SCHEMBL24312630 | 0.76 | — | — | |
| SCHEMBL21126457 | 0.75 | SMN1; SMN2 (0.30) | — | |
| SCHEMBL73800 | 0.75 | — | — | |
| SCHEMBL18721543 | 0.74 | — | — | |
| SCHEMBL23328619 | 0.73 | — | — | |
| SCHEMBL18827288 | 0.73 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4155062-B1 | METHOD OF FORMING AN OUTSOLE | NIKE INNOVATE CV (US) | 2024-06-26 | — | — | EP | disclosed |
| EP-3846793-B1 | EIF4E INHIBITORS AND USES THEREOF | PIC THERAPEUTICS INC (US) | 2024-01-24 | — | — | EP | disclosed |
| US-20230295437-A1 | SILICON CONTAINING DETECTABLE COMPOUNDS | Singular Genomics Systems, Inc. | 2023-09-21 | — | — | US | disclosed |
| US-20230295437-A1 | SILICON CONTAINING DETECTABLE COMPOUNDS | Singular Genomics Systems, Inc. | 2023-09-21 | — | — | US | disclosed |
| US-11713339-B2 | Macrocyclization of peptidomimetics | UNIVERSITY OF WARWICK (GB) | 2023-08-01 | — | — | US | disclosed |
| US-11708377-B2 | Analogues and derivatives of cephalotaxine and methods for making and using the compounds | OREGON STATE UNIVERSITY (US) | 2023-07-25 | — | — | US | disclosed |
| US-11697736-B2 | Silicon containing detectable compounds | Singular Genomics Systems, Inc. (US) | 2023-07-11 | — | — | US | disclosed |
| US-11697736-B2 | Silicon containing detectable compounds | Singular Genomics Systems, Inc. (US) | 2023-07-11 | — | — | US | disclosed |
| WO-2023064343-A1 | SMALL MOLECULE MODULATORS OF GLUCOCEREBROSIDASE ACTIVITY AND USES THEREOF | VANQUA BIO, INC. (US) | 2023-04-20 | — | — | WO | disclosed |
| US-11535754-B2 | Silicon containing detectable compounds and uses thereof | Singular Genomics Systems, Inc. (US) | 2022-12-27 | — | — | US | disclosed |
| EP-3924431-B1 | COLORANT SOLVENT SYSTEM, METHODS OF USE, AND ARTICLES | NIKE INNOVATE CV (US) | 2022-07-06 | — | — | EP | disclosed |
| US-10982124-B2 | Drill-in fluid compositions and methods | SAUDI ARABIAN OIL COMPANY (SA) | 2021-04-20 | — | — | US | disclosed |
| US-10907163-B1 | Aptamers that bind to natural and synthetic cannabinoids | THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES (US) | 2021-02-02 | — | — | US | disclosed |
| US-20210024579-A1 | MACROCYCLIZATION OF PEPTIDOMIMETICS | UNIVERSITY OF WARWICK (GB) | 2021-01-28 | — | — | US | disclosed |
| US-20190352508-A1 | SILICON CONTAINING DETECTABLE COMPOUNDS | FIRST-CITIZENS BANK & TRUST COMPANY | 2019-11-21 | — | — | US | disclosed |
| WO-2019164977-A1 | FLUORINATED NUCLEOTIDES AND USES THEREOF | Singular Genomics Systems, Inc. (US) | 2019-08-29 | — | — | WO | disclosed |
| US-10351752-B2 | Compositions and methods for sealing off flow channels in contact with set cement | SAUDI ARABIAN OIL COMPANY (SA) | 2019-07-16 | — | — | US | disclosed |
| US-20190136110-A1 | DRILL-IN FLUID COMPOSITIONS AND METHODS | SAUDI ARABIAN OIL COMPANY (SA) | 2019-05-09 | — | — | US | disclosed |
| US-20180127635-A1 | COMPOSITIONS AND METHODS FOR SEALING OFF FLOW CHANNELS IN CONTACT WITH SET CEMENT | ARAMCO SERVICES COMPANY | 2018-05-10 | — | — | US | disclosed |